First-line osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer

Citations

WEB OF SCIENCE

2

키워드

ACQUIRED-RESISTANCE; INHIBITOR AZD9291; NSCLC PATIENTS; CHEMOTHERAPY; MECHANISMS; MUTATIONS; GEFITINIB; TRIAL; ERLOTINIB; AFATINIB
제목
First-line osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer
저자
Jeong, Byeong-Ho; Um, Sang-Won
DOI
10.21037/atm.2017.12.30
발행일
2018-02
유형
Editorial Material
저널명
Annals of Translational Medicine
권
6
호
3